EGFR mutation in malignant pleural effusion of non-small cell lung cancer / 国际肿瘤学杂志
Journal of International Oncology
;
(12): 595-597, 2013.
Article
in Chinese
| WPRIM
| ID: wpr-437175
ABSTRACT
EGFR testing has become the consensus before epidermal growth factor-tyrosine kinase inhibitorrs (EGFR-TKIs) treatment in non-small cell lung cancer(NSCLC) patients.Malignant pleural effusion is the common clinical manifestation in NSCLC patients,and EGFR testing by using different methods in pleural effusion cells and free nucleic acids has good prospect for predicting the efficacy of EGFR-TKIs.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Prognostic study
Language:
Chinese
Journal:
Journal of International Oncology
Year:
2013
Type:
Article
Similar
MEDLINE
...
LILACS
LIS